127
Views
10
CrossRef citations to date
0
Altmetric
Case Report

A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection

ORCID Icon, , , ORCID Icon, , & show all
Pages 385-387 | Published online: 16 Apr 2021

References

  • Zhu Z, Ye Y, Cao H, et al. Clinical and dermoscopic manifestations of acute telogen effluvium. J Clin Dermatol. 2017;42(2):89–92.
  • Malkud S. Telogen effluvium: a review. J Clin DiagnRes. 2015;9(9):1–3.
  • Veraldi S, Vaira F, Raia DD, et al. Telogen effluvium as first clinical presentation of dengue. G Ital Dermatol Venereol. 2017;152(2):184–185. doi:10.23736/S0392-0488.16.05075-6
  • Rebora A, Ciccarese G, Drago F. Postfebrile telogen effluvium: hair fall after Rickettsia conorii infection. G Ital Dermatol Venereol. 2019;154(1):94–95. doi:10.23736/S0392-0488.17.05643-7
  • Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2020. doi:10.1016/j.cmi.2020.09.023
  • Moreno-Arrones OM, Lobato-Berezo A, Gomez-Zubiaur A, et al. SARS-CoV-2-induced telogen effluvium: a multicentric study. J Eur Acad Dermatol Venereol. 2020. doi:10.1111/jdv.17045
  • Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e278. doi:10.1016/j.cell.2020.02.052
  • Liu J, Li Y, Liu L, et al. Infection of human sweat glands by SARS-CoV-2. Cell Discov. 2020;6(1):84. doi:10.1038/s41421-020-00229-y
  • Turkmen D, Altunisik N, Sener S, et al. Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire. Dermatol Ther. 2020;33:e13923. doi:10.1111/dth.13923
  • Kutlu Ö, Metin A. Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID −19 pandemic. Dermatol Ther. 2020:e14096. doi:10.1111/dth.14096